21324189|t|Hippocampal expression of murine TNFalpha results in attenuation of amyloid deposition in vivo.
21324189|a| Fibrillar amyloid beta (fAbeta) peptide is the major component of Abeta plaques in the brains of Alzheimer's disease (AD) patients. Inflammatory mediators have previously been proposed to be drivers of Abeta pathology in AD patients by increasing amyloidogenic processing of APP and promoting Abeta accumulation, but recent data have shown that expression of various inflammatory cytokines attenuates Abeta pathology in mouse models. In an effort to further study the role of different inflammatory cytokines on Abeta pathology in vivo, we explored the effect of murine Tumor Necrosis Factor alpha (mTNFalpha) in regulating Abeta accumulation. Recombinant adeno-associated virus serotype 1 (AAV2/1) mediated expression of mTNFalpha in the hippocampus of 4 month old APP transgenic TgCRND8 mice resulted in significant reduction in hippocampal Abeta burden. No changes in APP levels or APP processing were observed in either mTNFalpha expressing APP transgenic mice or in non-transgenic littermates. Analysis of Abeta plaque burden in mTNFalpha expressing mice showed that even after substantial reduction compared to EGFP expressing age-matched controls, the Abeta plaque burden levels of the former do not decrease to the levels of 4 month old unmanipulated mice. Taken together, our data suggests that proinflammatory cytokine expression induced robust glial activation can attenuate plaque deposition. Whether such an enhanced microglial response actually clears preexisting deposits without causing bystander neurotoxicity remains an open question.
21324189	26	32	murine	Species	10090
21324189	33	41	TNFalpha	Gene	21926
21324189	68	86	amyloid deposition	Disease	MESH:D058225
21324189	121	127	fAbeta	Gene	2187
21324189	163	168	Abeta	Gene	351
21324189	194	213	Alzheimer's disease	Disease	MESH:D000544
21324189	215	217	AD	Disease	MESH:D000544
21324189	219	227	patients	Species	9606
21324189	229	241	Inflammatory	Disease	MESH:D007249
21324189	299	304	Abeta	Gene	351
21324189	318	320	AD	Disease	MESH:D000544
21324189	321	329	patients	Species	9606
21324189	390	395	Abeta	Gene	351
21324189	464	486	inflammatory cytokines	Disease	MESH:D000080424
21324189	498	503	Abeta	Gene	11820
21324189	517	522	mouse	Species	10090
21324189	583	605	inflammatory cytokines	Disease	MESH:D000080424
21324189	609	614	Abeta	Gene	351
21324189	660	666	murine	Species	10090
21324189	667	694	Tumor Necrosis Factor alpha	Gene	21926
21324189	721	726	Abeta	Gene	11820
21324189	753	786	adeno-associated virus serotype 1	Species	
21324189	788	794	AAV2/1	Species	
21324189	886	890	mice	Species	10090
21324189	940	945	Abeta	Gene	11820
21324189	1057	1061	mice	Species	10090
21324189	1108	1113	Abeta	Gene	11820
21324189	1152	1156	mice	Species	10090
21324189	1256	1261	Abeta	Gene	11820
21324189	1356	1360	mice	Species	10090
21324189	1610	1623	neurotoxicity	Disease	MESH:D020258
21324189	Negative_Correlation	MESH:D058225	21926
21324189	Association	MESH:D000544	351
21324189	Association	MESH:D000544	2187
21324189	Association	MESH:D007249	351
21324189	Negative_Correlation	MESH:D000080424	11820

